Viemed Healthcare Stock (NASDAQ:VMD)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$11.67

52W Range

$5.93 - $12.61

50D Avg

$10.82

200D Avg

$8.68

Market Cap

$451.22M

Avg Vol (3M)

$293.78K

Beta

1.10

Div Yield

-

VMD Company Profile


Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1,382

IPO Date

Aug 09, 2019

Website

VMD Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Service$24.89M$20.13M$10.66M
Equipment Sales$50.25M$30.90M$25.77M
COVID-19 Response Sales---

Fiscal year ends in Dec 25 | Currency in USD

VMD Financial Summary


Dec 25Dec 24Dec 23
Revenue$270.28M$224.26M$183.01M
Operating Income$22.95M$17.90M$14.33M
Net Income$14.93M$11.27M$10.24M
EBITDA$21.63M$42.31M$36.68M
Basic EPS$0.38$0.29$0.27
Diluted EPS$0.37$0.28$0.25

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 06, 26 | 11:00 AM
Q4 25Mar 05, 26 | 11:00 AM
Q3 25Nov 07, 25 | 11:00 AM

Peer Comparison


TickerCompany
SNWVSANUWAVE Health Inc.
SENSSenseonics Holdings, Inc.
QTRXQuanterix Corporation
INGNInogen, Inc.
SGHTSight Sciences, Inc.
MASS908 Devices Inc.
NNOXNano-X Imaging Ltd.
OMOutset Medical, Inc.
CVRXCVRx, Inc.